NO binding to Mn-substituted homoprotocatechuate 2,3-dioxygenase: relationship to O2 reactivity

被引:0
|
作者
Joshua A. Hayden
Erik R. Farquhar
Lawrence Que
John D. Lipscomb
Michael P. Hendrich
机构
[1] Carnegie Mellon University,Department of Chemistry
[2] University of Minnesota,Department of Chemistry
[3] University of Minnesota,Department of Biochemistry, Molecular Biology and Biophysics
关键词
Homoprotocatechuate dioxygenase; Manganese(II); Manganese(III); Nitric oxide; Electron paramagnetic resonance;
D O I
暂无
中图分类号
学科分类号
摘要
Iron(II)-containing homoprotocatechuate 2,3-dioxygenase (FeHPCD) activates O2 to catalyze the aromatic ring opening of homoprotocatechuate (HPCA). The enzyme requires FeII for catalysis, but MnII can be substituted (MnHPCD) with essentially no change in the steady-state kinetic parameters. Near simultaneous O2 and HPCA activation has been proposed to occur through transfer of an electron or electrons from HPCA to O2 through the divalent metal. In O2 reactions with MnHPCD–HPCA and the 4-nitrocatechol (4NC) complex of the His200Asn (H200N) variant of FeHPCD, this transfer has resulted in the detection of a transient MIII–O2·− species that is not observed during turnover of the wild-type FeHPCD. The factors governing formation of the MIII–O2·− species are explored here by EPR spectroscopy using MnHPCD and nitric oxide (NO) as an O2 surrogate. Both the HPCA and the dihydroxymandelic substrate complexes of MnHPCD bind NO, thus representing the first reported stable MnNO complexes of a nonheme enzyme. In contrast, the free enzyme, the MnHPCD–4NC complex, and the MnH200N and MnH200Q variants with or without HPCA bound do not bind NO. The MnHPCD–ligand complexes that bind NO are also active in normal O2-linked turnover, whereas the others are inactive. Past studies have shown that FeHPCD and the analogous variants and catecholic ligand complexes all bind NO, and are active in normal turnover. This contrasting behavior may stem from the ability of the enzyme to maintain the approximately 0.8-V difference in the solution redox potentials of FeII and MnII. Owing to the higher potential of Mn, the formation of the NO adduct or the O2 adduct requires both strong charge donation from the bound catecholic ligand and additional stabilization by interaction with the active-site His200. The same nonoptimal electronic and structural forces that prevent NO and O2 binding in MnHPCD variants may lead to inefficient electron transfer from the catecholic substrate to the metal center in variants of FeHPCD during O2-linked turnover. Accordingly, past studies have shown that intermediate FeIII species are observed for these mutant enzymes.
引用
收藏
页码:717 / 728
页数:11
相关论文
共 50 条
  • [41] Indoleamine 2,3-Dioxygenase Does It
    Hoogduijn, Martin J.
    TRANSPLANTATION, 2015, 99 (09) : 1751 - 1752
  • [42] Identification and Characterization of a Novel Dual Inhibitor of Indoleamine 2,3-dioxygenase 1 and Tryptophan 2,3-dioxygenase
    Yoshioka, Saeko
    Ikeda, Tomonori
    Fukuchi, Sogo
    Kawai, Yurika
    Ohta, Katsumi
    Murakami, Hisashi
    Ogo, Naohisa
    Muraoka, Daisuke
    Takikawa, Osamu
    Asai, Akira
    INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH, 2022, 15
  • [43] Indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase expression in HPV infection, SILs, and cervical cancer
    Venancio, Paloma Almeida
    Lopes Consolaro, Marcia Edilaine
    Derchain, Sophie Francoise
    Boccardo, Enrique
    Villa, Luisa Lina
    Maria-Engler, Silvya Stuchi
    Campa, Ana
    Discacciati, Michelle Garcia
    CANCER CYTOPATHOLOGY, 2019, 127 (09) : 586 - 597
  • [44] Docking and DFT studies on ligand binding to Quercetin 2,3-dioxygenase
    Malkhasian, Aramice Y. S.
    Howlin, Brendan J.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2016, 34 (11): : 2453 - 2461
  • [45] The Inhibitory Substrate Binding Site of Human Indoleamine 2,3-Dioxygenase
    Yeh, Syun-Ru
    Lewis-Ballester, Ariel
    Karkashon, Shay
    BIOPHYSICAL JOURNAL, 2013, 104 (02) : 562A - 562A
  • [46] Inhibitory Substrate Binding Site of Human Indoleamine 2,3-Dioxygenase
    Lu, Changyuan
    Lin, Yu
    Yeh, Syun-Ru
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2009, 131 (36) : 12866 - +
  • [47] 2,5-DIHYDRO-L-PHENYLALANINE - COMPETITIVE INHIBITOR OF INDOLEAMINE 2,3-DIOXYGENASE AND TRYPTOPHAN 2,3-DIOXYGENASE
    WATANABE, Y
    FUJIWARA, M
    HAYAISHI, O
    TAKEUCHI, T
    UMEZAWA, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1978, 85 (01) : 273 - 279
  • [48] Synthesis, structure, and reactivity of copper complexes as models for quercetin 2,3-dioxygenase
    Lynch, W
    Nivens, D
    Walsh, J
    Perkovic, MW
    Stone, J
    Sisco, P
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U35 - U35
  • [49] Enzyme Substrate Complex of the H200C Variant of Homoprotocatechuate 2,3-Dioxygenase: Mossbauer and Computational Studies
    Meier, Katlyn K.
    Rogers, Melanie S.
    Kovaleva, Elena G.
    Lipscomb, John D.
    Bominaar, Emile L.
    Munck, Eckard
    INORGANIC CHEMISTRY, 2016, 55 (12) : 5862 - 5870
  • [50] INHIBITION OF INDOLEAMINE 2,3-DIOXYGENASE AND TRYPTOPHAN 2,3-DIOXYGENASE BY BETA-CARBOLINE AND INDOLE-DERIVATIVES
    EGUCHI, N
    WATANABE, Y
    KAWANISHI, K
    HASHIMOTO, Y
    HAYAISHI, O
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1984, 232 (02) : 602 - 609